Research IPOs and Discover New Stocks
While market jitters have kept some IPO candidates on the sidelines, biotechs continue to tap the public market, with two more on the calendar for the week ahead. RNA interference biotech City Therapeutics (CTY) plans to raise $175 million at a $1.0 billion...read more
Two biotechs priced IPOs this past week and more joined the pipeline, along with a billion-dollar data center developer, an emerging markets fintech, and a dental treatment company. Autoimmune biotech TRex Bio (TRXB) priced at the low end to raise $117...read more
Bambusa Therapeutics, a Phase 2 biotech developing bispecific antibodies for inflammatory diseases, filed on Friday with the SEC to raise up to $100 million in an initial public offering. Bambusa Therapeutics is a clinical-stage biotech developing long-acting...read more
Track the top IPOs from the past 3 years by market cap.
| Company | Ticker | Shares (M) | Price Range | Deal Size ($M) | Underwriters | |
|---|---|---|---|---|---|---|
| City Therapeutics | CTY | Get date on IPO Pro | 9.7 | $17.00 - $19.00 | $175 | Goldman Jefferies |
| Iambic Therapeutics | IAM | Get date on IPO Pro | 9.4 | $15.00 - $17.00 | $150 | JP Morgan Jefferies |
IPO PRO TIP
Create custom screens and filters to see when IPOs are coming up. Explore full IPO Calendar
| Company | Ticker | Offer Date | Deal Size ($M) | Current Price | Today's Change | Return from IPO |
|---|---|---|---|---|---|---|
| Retension Pharmaceuticals | RTSN | 10/08/26 | $45 | $10.53 |
$0.00
(0.0%)
|
-12.3% |
| TRex Bio | TRXB | 10/08/26 | $117 | $14.00 |
$0.00
(0.0%)
|
0.0% |
| Accelevation | ACCV | 09/29/26 | $540 | $16.72 |
$0.00
(0.0%)
|
-7.1% |
IPO PRO TIP
The IPO price is the price the underwriters will sell stock to institutional and accredited investors. Learn more at IPO University
Get the Preview
Enhance your knowledge with IPO Pro. Screen for new stocks and find opportunities that others miss.
Start your 7-day trial of IPO Pro
